Upgrade to SI Premium - Free Trial

GlucoTrack (GCTK)

0.31 -0.06 (16.22%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (9/25/26 *Est.)

Latest Headlines

Form ARS Glucotrack, Inc. For: Dec 31 July 17, 2026 5:00 PM - SEC Filing Form DEF 14A Glucotrack, Inc. For: Jul 17 July 17, 2026 4:46 PM - SEC Filing E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Conve July 17, 2026 1:21 PM - StreetInsider E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million C July 17, 2026 1:20 PM - Globe NewsWire Glucotrack completes bridge financing after Lōkahi merger July 17, 2026 8:06 AM - StreetInsider Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets July 17, 2026 8:05 AM - Globe NewsWire Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Ini July 17, 2026 8:05 AM - StreetInsider Glucotrack completes merger with Lōkahi Therapeutics, ceding control July 16, 2026 4:58 PM - StreetInsider UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform July 16, 2026 4:57 PM - StreetInsider Form 425 Glucotrack, Inc. Filed by: Glucotrack, Inc. July 15, 2026 5:21 PM - SEC Filing Form 8-K Glucotrack, Inc. For: Jul 09 July 15, 2026 5:20 PM - SEC Filing Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform July 14, 2026 5:40 PM - Globe NewsWire USPTO allows Glucotrack patent for implantable glucose monitor July 8, 2026 8:00 AM - StreetInsider Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform July 8, 2026 8:00 AM - StreetInsider Form PRE 14A Glucotrack, Inc. For: Jun 17 June 17, 2026 5:03 PM - SEC Filing Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions May 26, 2026 8:00 AM - StreetInsider Form 8-K Glucotrack, Inc. For: May 15 May 15, 2026 4:46 PM - SEC Filing Form SCHEDULE 13G/A Glucotrack, Inc. Filed by: ARMISTICE CAPITAL, LLC May 15, 2026 11:18 AM - SEC Filing Form 10-Q Glucotrack, Inc. For: Mar 31 May 14, 2026 5:28 PM - SEC Filing Form 8-K Glucotrack, Inc. For: May 14 May 14, 2026 5:27 PM - SEC Filing Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights May 14, 2026 5:27 PM - Globe NewsWire Form 8-K Glucotrack, Inc. For: May 07 May 7, 2026 4:08 PM - SEC Filing Glucotrack submits FDA application for implantable glucose monitor study May 7, 2026 1:02 PM - StreetInsider Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology May 7, 2026 1:00 PM - StreetInsider Form EFFECT Glucotrack, Inc. May 1, 2026 9:20 AM - SEC Filing Form 8-K Glucotrack, Inc. For: Apr 29 April 30, 2026 5:21 PM - SEC Filing Form 8-K Glucotrack, Inc. For: Apr 30 April 30, 2026 10:18 AM - SEC Filing Glucotrack publishes glucose monitoring study showing 240-day accuracy April 30, 2026 9:02 AM - StreetInsider Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology April 30, 2026 9:00 AM - StreetInsider Form POS AM Glucotrack, Inc. April 29, 2026 5:29 PM - SEC Filing Full Article List